These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10798768)

  • 21. Effects of virus expressing CTLA4-IG and IL1-RA on islet xenografts.
    Lu WT; Lee WC; Hsu BR; Juang JH; Fu SH; Kuo CH
    Transplant Proc; 2001; 33(1-2):713-4. PubMed ID: 11267033
    [No Abstract]   [Full Text] [Related]  

  • 22. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation with CTLA4-Ig in islet transplantation.
    Benhamou PY
    Transplantation; 2002 Jan; 73(1 Suppl):S40-2. PubMed ID: 11810061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression.
    Ariyan C; Salvalaggio P; Fecteau S; Deng S; Rogozinski L; Mandelbrot D; Sharpe A; Sayegh MH; Basadonna GP; Rothstein DM
    J Immunol; 2003 Dec; 171(11):5673-7. PubMed ID: 14634073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking the immunoregulatory mechanisms active during allograft tolerance.
    Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
    J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation tolerance induced by CTLA4-Ig.
    Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
    Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of triple costimulation blockade on islet allograft survival in sensitized mice.
    Diab R; Iwata T; Corbascio M; Tibell A; Ekberg H; Holgersson J; Kumagai-Braesch M
    Transplant Proc; 2010; 42(6):2109-11. PubMed ID: 20692420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection.
    Guo Z; Mital D; Mo YY; Tian Y; Shen J; Chong AS; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplant Proc; 1998 Mar; 30(2):589. PubMed ID: 9532189
    [No Abstract]   [Full Text] [Related]  

  • 38. CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.
    Roy-Chaudhury P; Nickerson PW; Manfro RC; Zheng XX; Steiger J; Li YS; Strom TB
    Transplantation; 1997 Jul; 64(1):172-5. PubMed ID: 9233722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
    Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
    Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.